MedTrace Logo

Five Year Oncological Outcome After CME for Sigmoid Colon Cancer

NCT03774134 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 920

Last updated 2024-06-26

No results posted yet for this study

Summary

Study based in existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III sigmoid colon cancer

Conditions

  • Sigmoid Neoplasms

Interventions

PROCEDURE

Complete mesocolic excision

Based on the principles of CME. The inferior mesenteric artery (IMA) was divided at its origin from the aorta to perform central lymph nodes dissection along the IMA between the aorta and the branching of the left colic artery. Sigmoid resection included the complete sigmoid colon and resection of the upper part of the rectum to ensure sufficient perfusion of the colo-rectal anastomosis. To achieve sufficient distance at the proximal bowel resection margin, parts of the descending colon or even left hemicolectomy were performed at the surgeon's discretion.

PROCEDURE

Conventional colon resection

The patients underwent what was considered standard colon cancer resections in Denmark during the study period.

Sponsors & Collaborators

  • Bispebjerg Hospital

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Hvidovre University Hospital

    collaborator OTHER

  • Zealand University Hospital

    collaborator OTHER

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Claus A Bertelsen, PhD, MD · Department of Surgery, Nordsjaellands Hospital Hillerød

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-01
Primary Completion
2019-01-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774134 on ClinicalTrials.gov